What's happening
This bill requires New York's Medicaid program and managed care providers to cover FDA-approved prescription drugs for chronic weight management in adults with obesity.
Why it matters
Improves access to obesity treatments for low-income adults. By mandating Medicaid and managed care coverage, the bill ensures that adults with obesity who have related health conditions (like diabetes or hypertension) can obtain effective, FDA-approved weight management drugs—options that were previously out of reach for many due to cost.
Addresses health disparities and chronic disease prevention. Obesity is linked to numerous chronic diseases. This bill may help reduce long-term healthcare costs and improve health outcomes in vulnerable populations by enabling earlier intervention and management.
Signals a shift in recognizing obesity as a treatable medical condition. Requiring coverage for these medications moves away from viewing obesity solely as a lifestyle issue, treating it instead as a medical condition deserving of pharmaceutical intervention—potentially reducing stigma and supporting broader public health strategies.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Expand Access to Weight Drugs
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Expand Access to Weight Drugs
In Assembly Committee · Health · Sponsor Jake Ryan Blumencranz
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
9584
IN SENATE
May 16, 2024
Introduced by Sen. SEPULVEDA -- read twice and ordered printed, and when printed to be committed to the Committee on Health
AN ACT to amend the social services law, in relation to expanding access to prescription drugs approved by the FDA for chronic weight management
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. The social services law is amended by adding a new section 368-g to read as follows:
§ 368-g. Chronic weight management prescription drug accessibility. Notwithstanding any provision of law to the contrary, managed care providers and the medical assistance program shall cover prescription drugs approved by the federal food and drug administration for chronic weight management in adults with obesity with at least one weight-related condition.
§ 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD15451-01-4
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the social services law, in relation to expanding access to prescription drugs approved by the FDA for chronic weight management
Purpose
To provide Medicaid coverage for prescription drugs approved by the FDA for chronic weight loss to ensure greater healthcare accessibility and address the rising epidemic of obesity in our State.
Summary of provisions
Section 1 amends the social services law to add a new section 368-g to require managed care providers and the medical assistance program to cover prescription drugs approved by the federal food and drug adminis- tration for chronic weight management in adults with obesity with at least one weight-related condition.
Section 2 sets the effective date at immediately
Justification
The proposed legislation seeks to ensure that Medicaid prescription drug coverage includes prescription drugs approved by the FDA for chronic weight loss.
Obesity is a complex health issue with significant medical, social, and economic implications. According to the Centers for Disease Control and Prevention (CDC), obesity affects approximately 42.4% of adults in the United States, contributing to various chronic conditions such as diabetes, heart disease, and certain cancers. Despite the availability of FDA-approved prescription drugs for weight management, many individ- uals, particularly those from low-income backgrounds, face barriers to accessing these medications due to limited insurance coverage, especial- ly in New York State where Medicaid does not presently cover prescription drugs approved by the FDA for chronic weight loss.
This legislation aims to address this disparity by ensuring that indi- viduals enrolled in Medicaid in New York State have access to evidence- based treatment options for managing obesity. It is imperative that communities from all socioeconomic backgrounds are empowered to pursue healthier lifestyles, reduce the burden of obesity-related diseases on our state's healthcare system, and ultimately improve the overall well- being of our communities. Further, investing in preventative measures such as weight management can lead to long-term cost savings by reducing the incidence of obesity-related healthcare expenses. By providing access to FDA-approved prescription drugs for chronic weight loss through our state's Medicaid program, we can promote health equity and support the efforts of individuals striving to achieve and maintain a healthy weight.
Legislative history
New bill.
Fiscal implications
Minimal.
Effective date
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.